Literature DB >> 24611476

Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

M Kolpen1, T Bjarnsholt, C Moser, C R Hansen, L F Rickelt, M Kühl, C Hempel, T Pressler, N Høiby, P Ø Jensen.   

Abstract

Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients is characterized by persisting mucoid biofilms in hypoxic endobronchial mucus. These biofilms are surrounded by numerous polymorphonuclear leucocytes (PMNs), which consume a major part of present molecular oxygen (O(2)) due to production of superoxide (O(2)(-)). In this study, we show that the PMNs also consume O(2) for production of nitric oxide (NO) by the nitric oxide synthases (NOS) in the infected endobronchial mucus. Fresh expectorated sputum samples (n = 28) from chronically infected CF patients (n = 22) were analysed by quantifying and visualizing the NO production. NO production was detected by optode measurements combined with fluorescence microscopy, flow cytometry and spectrophotometry. Inhibition of nitric oxide synthases (NOS) with N(G) -monomethyl-L-arginine (L-NMMA) resulted in reduced O(2) consumption (P < 0·0008, n = 8) and a lower fraction of cells with fluorescence from the NO-indicator 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM) (P < 0·002, n = 8). PMNs stained with DAF-FM and the superoxide indicator hydroethidine (HE) and host cells with inducible NOS (iNOS) were identified in the sputum. In addition, the production of the stable end-products of NO in CF sputum was correlated with the concentration of PMNs; NO(3)(-) (P < 0·04, r = 0·66, n = 10) and NO(2)(-) (P< 0·006, r = 0·78, n = 11). The present study suggests that besides consumption of O(2) for production of reactive oxygen species, the PMNs in CF sputum also consume O(2) for production of NO.
© 2014 British Society for Immunology.

Entities:  

Keywords:  Pseudomonas aeruginosa; cystic fibrosis; neutrophil biology; nitric oxide; pneumonia

Mesh:

Substances:

Year:  2014        PMID: 24611476      PMCID: PMC4089181          DOI: 10.1111/cei.12318

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  59 in total

1.  Utility of gram stain in evaluation of sputa from patients with cystic fibrosis.

Authors:  E Sadeghi; A Matlow; I MacLusky; M A Karmali
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

2.  Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria.

Authors:  T J Evans; L D Buttery; A Carpenter; D R Springall; J M Polak; J Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

3.  Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.

Authors:  Kelli L Palmer; Stacie A Brown; Marvin Whiteley
Journal:  J Bacteriol       Date:  2007-03-30       Impact factor: 3.490

Review 4.  Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Authors:  Daniel J Hassett; John Cuppoletti; Bruce Trapnell; Sergei V Lymar; John J Rowe; Sang Sun Yoon; George M Hilliard; Kislay Parvatiyar; Moneesha C Kamani; Daniel J Wozniak; Sung Hei Hwang; Timothy R McDermott; Urs A Ochsner
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

5.  Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils.

Authors:  Y Yui; R Hattori; K Kosuga; H Eizawa; K Hiki; S Ohkawa; K Ohnishi; S Terao; C Kawai
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

6.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

7.  P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs.

Authors:  Oana Ciofu; Helle Krogh Johansen; Kasper Aanaes; Tina Wassermann; Morten Alhede; Christian von Buchwald; Niels Høiby
Journal:  J Cyst Fibros       Date:  2013-03-09       Impact factor: 5.482

8.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993

9.  Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils.

Authors:  M C Carreras; G A Pargament; S D Catz; J J Poderoso; A Boveris
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

10.  Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

Authors:  H Kojima; N Nakatsubo; K Kikuchi; S Kawahara; Y Kirino; H Nagoshi; Y Hirata; T Nagano
Journal:  Anal Chem       Date:  1998-07-01       Impact factor: 6.986

View more
  16 in total

Review 1.  Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?

Authors:  Kamal Dua; Shakti D Shukla; Rakesh K Tekade; Philip M Hansbro
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 2.  Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.

Authors:  Christina K Lin; Barbara I Kazmierczak
Journal:  J Innate Immun       Date:  2017-02-22       Impact factor: 7.349

3.  Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.

Authors:  Andrew J McDermott; Charles R Frank; Nicole R Falkowski; Roderick A McDonald; Vincent B Young; Gary B Huffnagle
Journal:  Gut Microbes       Date:  2014-07-21

4.  Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.

Authors:  Philip S Stewart; Ben White; Laura Boegli; Timothy Hamerly; Kerry S Williamson; Michael J Franklin; Brian Bothner; Garth A James; Steve Fisher; Francisco G Vital-Lopez; Anders Wallqvist
Journal:  J Bacteriol       Date:  2019-10-21       Impact factor: 3.490

5.  The O2-independent pathway of ubiquinone biosynthesis is essential for denitrification in Pseudomonas aeruginosa.

Authors:  Chau-Duy-Tam Vo; Julie Michaud; Sylvie Elsen; Bruno Faivre; Emmanuelle Bouveret; Frédéric Barras; Marc Fontecave; Fabien Pierrel; Murielle Lombard; Ludovic Pelosi
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

Review 6.  The structure-function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment.

Authors:  Mads Lichtenberg; Tim Holm Jakobsen; Michael Kühl; Mette Kolpen; Peter Østrup Jensen; Thomas Bjarnsholt
Journal:  FEMS Microbiol Rev       Date:  2022-09-02       Impact factor: 15.177

Review 7.  A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs.

Authors:  Brittan S Scales; Robert P Dickson; Gary B Huffnagle
Journal:  J Leukoc Biol       Date:  2016-06-30       Impact factor: 4.962

8.  Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum.

Authors:  Laura Line; Morten Alhede; Mette Kolpen; Michael Kühl; Oana Ciofu; Thomas Bjarnsholt; Claus Moser; Masanori Toyofuku; Nobuhiko Nomura; Niels Høiby; Peter Ø Jensen
Journal:  Front Microbiol       Date:  2014-10-24       Impact factor: 5.640

9.  Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin.

Authors:  Mette Kolpen; Christian J Lerche; Kasper N Kragh; Thomas Sams; Klaus Koren; Anna S Jensen; Laura Line; Thomas Bjarnsholt; Oana Ciofu; Claus Moser; Michael Kühl; Niels Høiby; Peter Ø Jensen
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

10.  Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.

Authors:  Mette Kolpen; Cecilie F Appeldorff; Sarah Brandt; Nabi Mousavi; Kasper N Kragh; Sevtap Aydogan; Haleema A Uppal; Thomas Bjarnsholt; Oana Ciofu; Niels Høiby; Peter Ø Jensen
Journal:  Pathog Dis       Date:  2015-10-12       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.